Hutchison Medipharma Limited
Records under this name other than the patents Hutchison Medipharma Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 28 patents it holds.
Back to Hutchison Medipharma Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,658,658 | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,519,142 | Crystalline Forms of 6-((6,7-Dimethoxyquinazolin-4-yl)oxy)-N,2-Dimethylbenzofuran-3-Carboxamide Formerly held In force · High confidence | In force | High confidence | |
| US 11,046,674 | Crystalline Forms of 6-((6,7-Dimethoxyquinazolin-4-YL)OXY)-N,2-Dimethylbenzofuran-3-Carboxamide Formerly held In force · High confidence | In force | High confidence | |
| US 11,958,838 | Crystalline Forms of 6-((6,7-Dimethoxyquinazolin-4-YL)OXY)-N,2-Dimethylbenzofuran-3-Carboxamide Formerly held In force · High confidence | In force | High confidence | |
| US 12,030,951 | ANTI-OX40 Antibody and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 12,134,613 | Improved Method for the Manufacture of 3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine and polymorphic forms thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,346,810 | Pyrrolopyrimidine compounds and uses thereof Lapsed on the fee record Ended May 24, 2024 · USPTO record | Lapsed on the fee record | Ended May 24, 2024 | USPTO record |
| US 9,168,253 | Quinazoline compounds Lapsed on the fee record Ended Oct 27, 2023 · USPTO record | Lapsed on the fee record | Ended Oct 27, 2023 | USPTO record |
| US 10,369,153 | Pyrrolopyrimidine compounds and uses thereof Lapsed on the fee record Ended Aug 6, 2023 · USPTO record | Lapsed on the fee record | Ended Aug 6, 2023 | USPTO record |
| US 10,111,875 | Pyrrolopyrimidine compounds and uses thereof Lapsed on the fee record Ended Oct 30, 2022 · USPTO record | Lapsed on the fee record | Ended Oct 30, 2022 | USPTO record |